- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 356381, 9 pages
Assessing the Metabolic Effects of Aromatherapy in Human Volunteers
1Center for Translational Medicine and Shanghai Key Laboratory of Diabetes Mellitus, Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, China
2School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai 200240, China
3Center for Translational Biomedical Research, University of North Carolina at Greensboro, Kannapolis, NC 28081, USA
Received 4 January 2013; Revised 12 April 2013; Accepted 14 April 2013
Academic Editor: Aiping Lu
Copyright © 2013 Yinan Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- M. S. Lee, J. Choi, P. Posadzki, and E. Ernst, “Aromatherapy for health care: an overview of systematic reviews,” Maturitas, vol. 71, no. 3, pp. 257–260, 2012.
- M. Lis-Balchin, “Essential oils and “aromatherapy”: their modern role in healing,” Journal of the Royal Society of Health, vol. 117, no. 5, pp. 324–329, 1997.
- G. Buchbauer, L. Jirovetz, W. Jager, C. Plank, and H. Dietrich, “Fragrance compounds and essential oils with sedative effects upon inhalation,” Journal of Pharmaceutical Sciences, vol. 82, no. 6, pp. 660–664, 1993.
- J. Lehrner, G. Marwinski, S. Lehr, P. Johren, and L. Deecke, “Ambient odors of orange and lavender reduce anxiety and improve mood in a dental office,” Physiology and Behavior, vol. 86, no. 1-2, pp. 92–95, 2005.
- B. F. Bradley, N. J. Starkey, S. L. Brown, and R. W. Lea, “The effects of prolonged rose odor inhalation in two animal models of anxiety,” Physiology and Behavior, vol. 92, no. 5, pp. 931–938, 2007.
- T. Umezu, K. Nagano, H. Ito, K. Kosakai, M. Sakaniwa, and M. Morita, “Anticonflict effects of lavender oil and identification of its active constituents,” Pharmacology Biochemistry and Behavior, vol. 85, no. 4, pp. 713–721, 2006.
- M. Komiya, T. Takeuchi, and E. Harada, “Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice,” Behavioural Brain Research, vol. 172, no. 2, pp. 240–249, 2006.
- T. Umezu, “Evidence for dopamine involvement in ambulation promoted by pulegone in mice,” Pharmacology Biochemistry and Behavior, vol. 94, no. 4, pp. 497–502, 2010.
- Y. N. Wu, Y. N. Zhang, G. X. Xie, et al., “The metabolic responses to aerial diffusion of essential oils,” PLOS One, vol. 7, no. 9, Article ID e44830, 2012.
- G. van der Watt and A. Janca, “Aromatherapy in nursing and mental health care,” Contemporary Nurse, vol. 30, no. 1, pp. 69–75, 2008.
- A. E. Edris, “Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review,” Phytotherapy Research, vol. 21, no. 4, pp. 308–323, 2007.
- Y. Ni, M. Su, Y. Qiu et al., “Metabolic profiling using combined GC-MS and LC-MS provides a systems understanding of aristolochic acid-induced nephrotoxicity in rat,” FEBS Letters, vol. 581, no. 4, pp. 707–711, 2007.
- P. Jonsson, J. Gullberg, A. Nordström et al., “A strategy for identifying differences in large series of metabolomic samples analyzed by GC/MS,” Analytical Chemistry, vol. 76, no. 6, pp. 1738–1745, 2004.
- P. Jonsson, A. I. Johansson, J. Gullberg et al., “High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses,” Analytical Chemistry, vol. 77, no. 17, pp. 5635–5642, 2005.
- G. Xie, R. Plumb, M. Su et al., “Ultra-performance LC/TOF MS analysis of medicinal Panax herbs for metabolomic research,” Journal of Separation Science, vol. 31, no. 6-7, pp. 1015–1026, 2008.
- W. S. Zhong and L. Li, “Research on the new SCL-90 model on Chinese university students,” Chinese Journal of School Doctor, vol. 23, no. 3, pp. 251–256, 2009.
- National Cancer Institute, U. S. N. I. o. H. Aromatherapy and essential oils (PDQs), http://www.cancer.gov/cancertopics/pdq/cam/aromatherapy/HealthProfessional.
- B. F. Bradley, N. J. Starkey, S. L. Brown, and R. W. Lea, “Anxiolytic effects of Lavandula angustifolia odour on the Mongolian gerbil elevated plus maze,” Journal of Ethnopharmacology, vol. 111, no. 3, pp. 517–525, 2007.
- D. Shaw, J. M. Annett, B. Doherty, and J. C. Leslie, “Anxiolytic effects of lavender oil inhalation on open-field behaviour in rats,” Phytomedicine, vol. 14, no. 9, pp. 613–620, 2007.
- M. M. Blanco, C. A. R. A. Costa, A. O. Freire, J. G. Santos, and M. Costa, “Neurobehavioral effect of essential oil of Cymbopogon citratus in mice,” Phytomedicine, vol. 16, no. 2-3, pp. 265–270, 2009.
- D. L. Clark and N. N. Boutros, The Brain and Behaviour: An Introduction to Behavioural Neuroanatomy, Blackwell Science, Oxford, UK, 1999.
- C. Holmes and C. Ballard, “Aromatherapy in dementia,” Advances in Psychiatric Treatment, vol. 10, no. 4, pp. 296–300, 2004.
- L. M. Chepulis, N. J. Starkey, J. R. Waas, and P. C. Molan, “The effects of long-term honey, sucrose or sugar-free diets on memory and anxiety in rats,” Physiology and Behavior, vol. 97, no. 3-4, pp. 359–368, 2009.
- J. Benjamin, J. Levine, M. Fux, A. Aviv, D. Levy, and R. H. Belmaker, “Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder,” American Journal of Psychiatry, vol. 152, no. 7, pp. 1084–1086, 1995.
- H. Einat and R. H. Belmaker, “The effects of inositol treatment in animal models of psychiatric disorders,” Journal of Affective Disorders, vol. 62, no. 1-2, pp. 113–121, 2001.
- J. Bouayed, H. Rammal, and R. Soulimani, “Oxidative stress and anxiety Relationship and cellular pathways,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 2, pp. 63–67, 2009.
- F. Ng, M. Berk, O. Dean, and A. I. Bush, “Oxidative stress in psychiatric disorders: evidence base and therapeutic implications,” International Journal of Neuropsychopharmacology, vol. 11, no. 6, pp. 851–876, 2008.
- M. Kuloglu, M. Atmaca, E. Tezcan, B. Ustundag, and S. Bulut, “Antioxidant enzyme and malondialdehyde levels in patients with panic disorder,” Neuropsychobiology, vol. 46, no. 4, pp. 186–189, 2002.
- S. Ersan, S. Bakir, E. Erdal Ersan, and O. Dogan, “Examination of free radical metabolism and antioxidant defence system elements in patients with obsessive-compulsive disorder,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 30, no. 6, pp. 1039–1042, 2006.
- T. T. Haug, A. Mykletun, and A. A. Dahl, “Are anxiety and depression related to gastrointestinal symptoms in the general population?” Scandinavian Journal of Gastroenterology, vol. 37, no. 3, pp. 294–298, 2002.
- G. W. Tannock, “New perceptions of the gut microbiota: implications for future research,” Gastroenterology Clinics of North America, vol. 34, no. 3, pp. 361–382, 2005.
- I. K. S. Yap, J. V. Li, J. Saric et al., “Metabonomic and microbiological analysis of the dynamic effect of vancomycin-lnduced gut microbiota modification in the mouse,” Journal of Proteome Research, vol. 7, no. 9, pp. 3718–3728, 2008.
- X. Zheng, G. Xie, A. Zhao, et al., “The footprints of gut microbial-mammalian co-metabolism,” Journal of Proteomic Research, vol. 10, no. 12, pp. 5512–5522, 2011.